Q-Pin SR 300 mg tablete s produljenim oslobađanjem
| Name | Q-Pin SR 300 mg tablete s produljenim oslobađanjem |
|---|---|
| Former Name | Kvetiapin Edicta SR 300 mg tablete s produljenim oslobađanjem |
| Marketing Authorisation Number | HR-H-402567482 |
| Active Substance | kvetiapinfumarat |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 300 mg kvetiapina u obliku kvetiapinfumarata |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder | Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date | 13.08.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/409 |
| Registration Number | 381-12-01/30-18-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N05AH04 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Educational materials for healthcare professionals |
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2 |
